NL-OMON55241
Recruiting
Not Applicable
Sickle Cell Outcome REsearch - SCORE
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 1000
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- A diagnosis of SCD of any genotype;
- •\- Written patient (and in case of a patient \<16 years of age, parental)
- •informed consent.
Exclusion Criteria
- •\- Any medical or social reason, which obstructs or inhibits study participation
- •according to treating physician
- •\- Intrekking van (ouderlijke) toestemming
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Sickle Cell Outcome ResearchNL-OMON29491A1,000
Not yet recruiting
Phase 4
A study that helps in Observing patients suffering from Sickle Cell Disease, when given a treatment of crizanlizumab in Middle Eastcountries and India (SPOTLIGHT)CTRI/2022/06/043467ovartis Healthcare Pvt Ltd
Recruiting
Phase 3
Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector2024-513901-30-00Bluebird Bio Inc.3
Recruiting
Phase 1
ong-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral VectorCTIS2024-513901-30-00Bluebird Bio Inc.88
Terminated
Not Applicable
Prospective, Observational Study in Sickle Cell Disease Patients on Crizanlizumab Treatment in Middle East Countries and IndiaSickle Cell DiseaseNCT05020873Novartis Pharmaceuticals44